| |
| |
|
| Insider
Information: |
Mueller Brian |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
81,859 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$6,368,863 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
81,859 |
|
|
| Total
Value |
$6,368,863 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biomarin Pharmaceutical Inc |
BMRN |
EVP, Chief Financial O... |
2024-03-15 |
71,859 |
|
0 |
Premium* |
|
|
Anthera Pharmaceuticals Inc |
ANTH |
|
2015-12-23 |
10,000 |
2015-12-23 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
136 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-06-15 |
4 |
AS |
$94.50 |
$190,985 |
D/D |
(2,021) |
13,029 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2015-03-03 |
4 |
OE |
$28.23 |
$197,610 |
D/D |
7,000 |
15,800 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-05-08 |
4 |
OE |
$11.74 |
$216,967 |
D/D |
15,708 |
29,392 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-05-10 |
4 |
AS |
$89.50 |
$219,275 |
D/D |
(2,450) |
15,396 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-08-05 |
4 |
OE |
$67.81 |
$237,335 |
D/D |
3,500 |
34,226 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-11-23 |
4 |
OE |
$67.81 |
$237,335 |
D/D |
3,500 |
32,347 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-03-15 |
4 |
D |
$87.74 |
$237,600 |
D/D |
(2,708) |
59,558 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-08-07 |
4 |
AS |
$104.50 |
$261,250 |
D/D |
(2,500) |
12,375 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2017-06-22 |
4 |
AS |
$100.00 |
$267,100 |
D/D |
(2,671) |
12,885 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-12-13 |
4 |
AS |
$107.50 |
$268,750 |
D/D |
(2,500) |
27,746 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2019-04-05 |
4 |
AS |
$94.00 |
$277,582 |
D/D |
(2,953) |
13,660 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-01-13 |
4 |
AS |
$114.50 |
$286,250 |
D/D |
(2,500) |
27,746 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-03-01 |
4 |
S |
$59.74 |
$300,067 |
D/D |
(5,023) |
15,294 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2014-11-26 |
4 |
S |
$88.97 |
$302,508 |
D/D |
(3,400) |
4,593 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
SVP, Corporate Controller |
• – – |
2018-06-22 |
4 |
AS |
$99.50 |
$312,928 |
D/D |
(3,145) |
12,375 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-08-05 |
4 |
AS |
$94.50 |
$330,750 |
D/D |
(3,500) |
30,726 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-05-14 |
4 |
S |
$70.33 |
$348,045 |
D/D |
(4,947) |
6,660 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2023-03-16 |
4 |
D |
$93.41 |
$371,118 |
D/D |
(3,973) |
55,585 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-11-05 |
4 |
AS |
$46.00 |
$376,250 |
D/D |
(8,000) |
15,340 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-12-02 |
4 |
OE |
$67.81 |
$400,079 |
D/D |
5,900 |
31,507 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2021-04-01 |
4 |
AS |
$76.30 |
$434,300 |
D/D |
(5,692) |
31,016 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2014-12-02 |
4 |
S |
$91.82 |
$459,100 |
D/D |
(5,000) |
4,593 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2012-11-15 |
4 |
OE |
$14.39 |
$477,085 |
D/D |
15,812 |
31,152 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
VP, Corporate Controller |
• – – |
2013-05-03 |
4 |
S |
$67.11 |
$503,295 |
D/D |
(7,500) |
9,403 |
0 |
- |
|
| BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Financial Officer |
• – – |
2022-11-23 |
4 |
AS |
$95.09 |
$531,092 |
D/D |
(5,379) |
28,847 |
0 |
- |
|
136 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
